Craig Venter’s biotech firm Synthetic Genomics is facing a lawsuit from a former attorney who worked at the firm, alleging gender discrimination.
New research has revealed that fathers pass on four times as many new genetic mutations as mother, making them a driver for rare childhood diseases.
UK scientists have edited the DNA of human embryos for the first time, helping them further understand infertility and miscarriage.
Could the technology we have developed to design viruses and vaccines one day be used to kill us? The answer boils down to who is in control.
Disorder in 1 gene triggers a chain reaction that disrupts the construction and stability of the brain’s developing connections
We’ve caught up with an excited Nikolai Slavov ahead of Festival of Genomics Boston, where he will be sharing new methods and results from his laboratory.
Genetic testing company Invitae have come under fire after making a mistake on its cancer screenings.
Sophia Genetics has raised $30 million in Series D funding in a bid to accelerate its mission of democratising data-driven medicine worldwide.
How some genes lost the ability to make proteins – and gained regulatory powers.
Cells can be programmed like a computer to fight cancer, influenza, and other serious conditions, thanks to a breakthrough in synthetic biology.
Craig Venter’s start-up, Human Longevity hasn’t fulfilled its promises as it faces backlash from critics.
New research suggests that exosomes, previously thought to be cell waste, could in fact be used to treat pancreatic cancer.
Mark Korson believes the medicinal field is in crisis, with not nearly enough “metabolically-trained” health professionals on hand to serve the needs of patients.